Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
New York, New York–(Newsfile Corp. – January 22, 2025) – WHY: Rosen Law Firm, a global investment law firm, reminds clients of Dentsply Sirona Inc.’s common stock. (NASDAQ: XRAY) between May 6, 2021 and November 6, 2024, both dates inclusive (the “Class Period”), significant January 27, 2025 schedule of the lead plaintiff.
NOW: If you have purchased Dentsply Sirona common stock during the Group period you may be entitled to compensation without paying fees or expenses through the contingency fee arrangement.
WHAT YOU NEED TO DO: To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has been filed. If you wish to act as the lead plaintiff, you must remove the Court before 27 January 2025. The lead plaintiff is the party representing the other members of the class to conduct the case.
WHY ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Oftentimes, the companies that issue the notices don’t have the experience, the resources, or any meaningful peer recognition. Most of these firms are not suing the actions of the security team, but are simply businessmen who refer clients or partner with law firms who are suing. Be smart when choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder litigation. The Rosen Law Firm has reached the largest settlement of a class action against a Chinese Company at that time. Rosen Law Firm is ranked No. 1 by ISS Securities Group Action (WA:) Services in the number of securities class settlements in 2017. The firm has been ranked 4th every year since 2013 and has secured hundreds of millions of dollars for investors. In 2019 alone, the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by Law360 as a Titan of Plaintiffs’ Bar. Most of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.
FACTS OF THE CASE: According to the lawsuit, during the Class Period, the defendants made false and/or misleading statements and/or failed to disclose material facts necessary to make the statements made, given the circumstances in which they were made , which is not false and misleading. In fact, Byte’s aligners have been causing serious injuries to patients since at least May 2021, as revealed in the backlog of injury reports that Dentsply Sirona filed with the US Food and Drug Administration (“FDA”) by 2024. At least part of the problem was that customer service personnel and supervising dentists were encouraged to enroll contraindicated patients with other dental problems who were he should prevent them from receiving Byte’s treatment. As a result, the defendants’ positive statements about Byte’s customer experience, and the extensive network of dentists who oversee and manage each customer’s treatment, were materially and materially misleading. / or they had no reasonable basis. In addition, Dentsply Sirona hid the fact that its high conversion rates were caused by sales incentives to register contraindicated patients. When the real facts entered the market, the lawsuit alleges that investors were harmed.
To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about a class action.
No Group Guaranteed. Until the group is confirmed, you are not represented by a counselor unless you have reserved one. You can choose a consultant of your choice. You can remain a member of the missing group and do nothing at this point. The investor’s ability to contribute to future recovery does not depend on serving as the primary plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): https: / /www.facebook.com/rosenlawfirm/.
Advertising Attorney. Preliminary results do not guarantee a similar outcome.
——————————
Contact information:
To view the source version of this release, please visit https://www.newsfilecorp.com/release/238134